先達股份(603086.SH):創新藥吡唑喹草酯獲得批准登記
格隆匯9月29日丨先達股份(603086.SH)公佈,本公司全資子公司遼寧先達農業科學有限公司申請的創新藥吡唑喹草酯登記已獲批准。
吡唑喹草酯是一種新型除草劑,作用機理屬於對羥苯基丙酮酸雙氧化酶(HPPD)抑制劑類。該產品在傳統HPPD抑制劑使用受限的秈稻田中,展現出優異的安全性和有效性,解決了農作物保護的核心難題。憑藉其獨特的機制,吡唑喹草酯能夠有效防治一系列抗性雜草,包括千金子、蟣子草等禾本科雜草,有望成為水稻田抗性雜草管理的重要工具。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.